Epidemiologic studies suggest a close association between hypertension, obesity, and diabetes. It has been demonstrated that essential hypertension, per se, is an insulin-resistant state. However, the pathogenesis of the association between insulin resistance and hypertension is poorly understood. Elevated plasma insulin levels may contribute to the development of hypertension through renal sodium reabsorption, the sympathetic nervous system, the transmembranous cation transport, the renin-angiotensin system, the cardiovascular reactivity, and the atrial natriuretic peptide. Diuretics, β-blockers, calcium antagonists, angiotensin-converting enzyme (ACE) inhibitors, and α1-antagonists are first-choice drugs in the management of hypertension. Diuretics, except indapamide, impair insulin sensitivity and glucose tolerance. The same negative effects, exerted by β-blockers, are reduced employing those with selective activity. With few exceptions, calcium antagonists have no adverse influence on carbohydrate metabolism. ACE inhibitors and α1-antagonists do not influence or even improve glucose metabolism.

Gambardella, S., Frontoni, S., Pellegrinotti, M., Testa, G., Spallone, V., MENZINGER DI PREUSSENTHAL, G.e. (1993). Carbohydrate metabolism in hypertension: influence of treatment. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 22(Suppl 6), S87-S97.

Carbohydrate metabolism in hypertension: influence of treatment

GAMBARDELLA, SERGIO;FRONTONI, SIMONA;SPALLONE, VINCENZA;MENZINGER DI PREUSSENTHAL, GUIDO ENRICO
1993-01-01

Abstract

Epidemiologic studies suggest a close association between hypertension, obesity, and diabetes. It has been demonstrated that essential hypertension, per se, is an insulin-resistant state. However, the pathogenesis of the association between insulin resistance and hypertension is poorly understood. Elevated plasma insulin levels may contribute to the development of hypertension through renal sodium reabsorption, the sympathetic nervous system, the transmembranous cation transport, the renin-angiotensin system, the cardiovascular reactivity, and the atrial natriuretic peptide. Diuretics, β-blockers, calcium antagonists, angiotensin-converting enzyme (ACE) inhibitors, and α1-antagonists are first-choice drugs in the management of hypertension. Diuretics, except indapamide, impair insulin sensitivity and glucose tolerance. The same negative effects, exerted by β-blockers, are reduced employing those with selective activity. With few exceptions, calcium antagonists have no adverse influence on carbohydrate metabolism. ACE inhibitors and α1-antagonists do not influence or even improve glucose metabolism.
1993
Pubblicato
Rilevanza internazionale
Articolo
Esperti anonimi
Settore MED/13 - ENDOCRINOLOGIA
English
Con Impact Factor ISI
Diabetes; Glucose metabolism; Hypertension; Insulin
Gambardella, S., Frontoni, S., Pellegrinotti, M., Testa, G., Spallone, V., MENZINGER DI PREUSSENTHAL, G.e. (1993). Carbohydrate metabolism in hypertension: influence of treatment. JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 22(Suppl 6), S87-S97.
Gambardella, S; Frontoni, S; Pellegrinotti, M; Testa, G; Spallone, V; MENZINGER DI PREUSSENTHAL, Ge
Articolo su rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/2108/95209
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 32
  • ???jsp.display-item.citation.isi??? ND
social impact